Transcatheter pulmonary valve implantation (TPVI) is a relatively new method of treating patients with significant pulmonary regurgitation or pulmonary stenosis, or both, after reconstruction of the right ventricular outflow tract. It is an attractive alternative to conduit replacement in this group of patients, who are typically young and active. This report includes 4 young women who after successful TPVI became pregnant and gave birth.
View Article and Find Full Text PDFBackground: The aim of the study was to evaluate the role of cardiopulmonary exercise testing (CPET) parameters in assessing exercise capacity improvement after percutaneous pulmonary valve implantation (PPVI). Additionally, it aimed to determine if there are any baseline characteristics influencing that change.
Methods And Results: The study comprised 32 patients (mean age 26 ± 9); 53% males; diagnosis: tetralogy of Fallot (n = 18), pulmonary atresia (n = 6), Ross procedure (n = 4), other (transposition of great arteries, pulmonary stenosis, double outlet right ventricle, common arterial trunk type II--n = 4) who underwent successful PPVI due to right ventricular out-flow tract dysfunction (predominant pulmonary regurgitation--n = 17, predominant pulmonary stenosis--n = 15).
Isolated left ventricular noncompaction is a primary, genetic cardiomyopathy thought to be caused by arrest of normal embryogenesis of endocardium and myocardium, characterised by a pattern of excessively prominent trabecular meshwork and deep intertrabecular recesses with to-and-from flow in continuity with the ventricular flow and the absence of other structural heart diseases. Isolated noncompaction of the ventricular myocardium is considered to predominantly affect the left ventricle. Our earlier observations suggest that both ventricles may be involved.
View Article and Find Full Text PDF